具有不同临床特征的抗精神病药物引起的膜分裂和结构重组。

IF 3.9 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Ana Gorse, , , Vesela Yordanova, , , Jessica Bodosa, , , Marion Mathelié-Guinlet, , , Astrid Walrant, , , Nada Taib-Mamaar, , , Axelle Grélard, , , Claire François-Martin, , , Rim Baccouch, , , Estelle Rascol, , , Gilmar F. Salgado, , , Maria João Moreno, , , Margarida Bastos, , , Jeffery B. Klauda*, , , Galya Staneva*, , , Philippe Nuss*, , and , Isabel D. Alves*, 
{"title":"具有不同临床特征的抗精神病药物引起的膜分裂和结构重组。","authors":"Ana Gorse,&nbsp;, ,&nbsp;Vesela Yordanova,&nbsp;, ,&nbsp;Jessica Bodosa,&nbsp;, ,&nbsp;Marion Mathelié-Guinlet,&nbsp;, ,&nbsp;Astrid Walrant,&nbsp;, ,&nbsp;Nada Taib-Mamaar,&nbsp;, ,&nbsp;Axelle Grélard,&nbsp;, ,&nbsp;Claire François-Martin,&nbsp;, ,&nbsp;Rim Baccouch,&nbsp;, ,&nbsp;Estelle Rascol,&nbsp;, ,&nbsp;Gilmar F. Salgado,&nbsp;, ,&nbsp;Maria João Moreno,&nbsp;, ,&nbsp;Margarida Bastos,&nbsp;, ,&nbsp;Jeffery B. Klauda*,&nbsp;, ,&nbsp;Galya Staneva*,&nbsp;, ,&nbsp;Philippe Nuss*,&nbsp;, and ,&nbsp;Isabel D. Alves*,&nbsp;","doi":"10.1021/acschemneuro.5c00339","DOIUrl":null,"url":null,"abstract":"<p >Antipsychotics (APs) are used in the treatment of severe mental disorders. Their mechanism of action involves interaction with multiple brain targets, notably the dopamine D2 receptor (D2R), where they compete with dopamine. Due to their lipophilic nature, APs also partition and accumulate in lipid membranes, particularly around the D2R and in synaptic vesicles. When intercalated into brain membranes, APs slowly accumulate and act as reservoirs, allowing their rapid release on demand to modulate neurotransmitter signaling. They also modify the physicochemical and mechanical properties of the lipid bilayer. These modifications can subsequently affect the conformational changes of embedded membrane proteins like the D2R. This study investigated two major APs with different pharmacological and clinical profiles: chlorpromazine, which exerts its clinical activity mainly through a strong antagonistic action at the D2R, and clozapine, the weakest D2R antagonist of all APs. Surprisingly, although D2R antagonism is usually associated with AP potency, clozapine has repeatedly demonstrated clinically superior efficacy to all APs and is therefore recommended for treatment-resistant schizophrenia. The current work aims to extend the classical AP receptor-mediated paradigmatic mode of action to their potential and unique membrane remodeling properties by thoroughly comparing their partitioning and impact on the physicochemical properties of the lipid membrane. Lipid model membranes mimicking synaptic vesicles have been investigated by using a combination of several biophysical methods. The study aims to determine how the partitioning of the two APs modifies membrane order, phase transition, thickness, elasticity, phase separation, membrane integrity, and charge. Differences have been demonstrated between these two compounds, which may further differ both over time as they accumulate, as well as depending on their pre- or postsynaptic location.</p>","PeriodicalId":13,"journal":{"name":"ACS Chemical Neuroscience","volume":"16 19","pages":"3728–3744"},"PeriodicalIF":3.9000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Membrane Partition and Structural Reorganization Induced by Antipsychotics with Distinct Clinical Profiles\",\"authors\":\"Ana Gorse,&nbsp;, ,&nbsp;Vesela Yordanova,&nbsp;, ,&nbsp;Jessica Bodosa,&nbsp;, ,&nbsp;Marion Mathelié-Guinlet,&nbsp;, ,&nbsp;Astrid Walrant,&nbsp;, ,&nbsp;Nada Taib-Mamaar,&nbsp;, ,&nbsp;Axelle Grélard,&nbsp;, ,&nbsp;Claire François-Martin,&nbsp;, ,&nbsp;Rim Baccouch,&nbsp;, ,&nbsp;Estelle Rascol,&nbsp;, ,&nbsp;Gilmar F. Salgado,&nbsp;, ,&nbsp;Maria João Moreno,&nbsp;, ,&nbsp;Margarida Bastos,&nbsp;, ,&nbsp;Jeffery B. Klauda*,&nbsp;, ,&nbsp;Galya Staneva*,&nbsp;, ,&nbsp;Philippe Nuss*,&nbsp;, and ,&nbsp;Isabel D. Alves*,&nbsp;\",\"doi\":\"10.1021/acschemneuro.5c00339\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Antipsychotics (APs) are used in the treatment of severe mental disorders. Their mechanism of action involves interaction with multiple brain targets, notably the dopamine D2 receptor (D2R), where they compete with dopamine. Due to their lipophilic nature, APs also partition and accumulate in lipid membranes, particularly around the D2R and in synaptic vesicles. When intercalated into brain membranes, APs slowly accumulate and act as reservoirs, allowing their rapid release on demand to modulate neurotransmitter signaling. They also modify the physicochemical and mechanical properties of the lipid bilayer. These modifications can subsequently affect the conformational changes of embedded membrane proteins like the D2R. This study investigated two major APs with different pharmacological and clinical profiles: chlorpromazine, which exerts its clinical activity mainly through a strong antagonistic action at the D2R, and clozapine, the weakest D2R antagonist of all APs. Surprisingly, although D2R antagonism is usually associated with AP potency, clozapine has repeatedly demonstrated clinically superior efficacy to all APs and is therefore recommended for treatment-resistant schizophrenia. The current work aims to extend the classical AP receptor-mediated paradigmatic mode of action to their potential and unique membrane remodeling properties by thoroughly comparing their partitioning and impact on the physicochemical properties of the lipid membrane. Lipid model membranes mimicking synaptic vesicles have been investigated by using a combination of several biophysical methods. The study aims to determine how the partitioning of the two APs modifies membrane order, phase transition, thickness, elasticity, phase separation, membrane integrity, and charge. Differences have been demonstrated between these two compounds, which may further differ both over time as they accumulate, as well as depending on their pre- or postsynaptic location.</p>\",\"PeriodicalId\":13,\"journal\":{\"name\":\"ACS Chemical Neuroscience\",\"volume\":\"16 19\",\"pages\":\"3728–3744\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Chemical Neuroscience\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acschemneuro.5c00339\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Chemical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acschemneuro.5c00339","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

抗精神病药物(APs)用于治疗严重的精神障碍。它们的作用机制涉及与多个大脑目标的相互作用,特别是多巴胺D2受体(D2R),在那里它们与多巴胺竞争。由于其亲脂性,APs也在脂质膜中分裂和积聚,特别是在D2R周围和突触囊泡中。当植入脑膜时,ap会缓慢积累并充当储物库,允许它们根据需要快速释放以调节神经递质信号。它们还改变了脂质双分子层的物理化学和机械性质。这些修饰随后会影响嵌入膜蛋白如D2R的构象变化。本研究研究了两种具有不同药理和临床特征的主要ap:氯丙嗪和氯氮平,氯丙嗪主要通过对D2R的强拮抗作用发挥其临床活性,氯氮平是所有ap中最弱的D2R拮抗剂。令人惊讶的是,虽然D2R拮抗剂通常与AP效价有关,但氯氮平在临床上一再显示出优于所有AP的疗效,因此被推荐用于治疗难治性精神分裂症。目前的工作旨在通过全面比较它们的分配和对脂质膜物理化学性质的影响,将经典的AP受体介导的范式作用模式扩展到它们的潜力和独特的膜重塑特性。脂质模型膜模拟突触囊泡已被研究使用几种生物物理方法的组合。该研究旨在确定两种ap的分配如何改变膜的顺序、相变、厚度、弹性、相分离、膜完整性和电荷。这两种化合物之间的差异已经被证明,随着时间的推移,它们的积累可能会进一步不同,也取决于它们在突触前或突触后的位置。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Membrane Partition and Structural Reorganization Induced by Antipsychotics with Distinct Clinical Profiles

Membrane Partition and Structural Reorganization Induced by Antipsychotics with Distinct Clinical Profiles

Antipsychotics (APs) are used in the treatment of severe mental disorders. Their mechanism of action involves interaction with multiple brain targets, notably the dopamine D2 receptor (D2R), where they compete with dopamine. Due to their lipophilic nature, APs also partition and accumulate in lipid membranes, particularly around the D2R and in synaptic vesicles. When intercalated into brain membranes, APs slowly accumulate and act as reservoirs, allowing their rapid release on demand to modulate neurotransmitter signaling. They also modify the physicochemical and mechanical properties of the lipid bilayer. These modifications can subsequently affect the conformational changes of embedded membrane proteins like the D2R. This study investigated two major APs with different pharmacological and clinical profiles: chlorpromazine, which exerts its clinical activity mainly through a strong antagonistic action at the D2R, and clozapine, the weakest D2R antagonist of all APs. Surprisingly, although D2R antagonism is usually associated with AP potency, clozapine has repeatedly demonstrated clinically superior efficacy to all APs and is therefore recommended for treatment-resistant schizophrenia. The current work aims to extend the classical AP receptor-mediated paradigmatic mode of action to their potential and unique membrane remodeling properties by thoroughly comparing their partitioning and impact on the physicochemical properties of the lipid membrane. Lipid model membranes mimicking synaptic vesicles have been investigated by using a combination of several biophysical methods. The study aims to determine how the partitioning of the two APs modifies membrane order, phase transition, thickness, elasticity, phase separation, membrane integrity, and charge. Differences have been demonstrated between these two compounds, which may further differ both over time as they accumulate, as well as depending on their pre- or postsynaptic location.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Chemical Neuroscience
ACS Chemical Neuroscience BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
CiteScore
9.20
自引率
4.00%
发文量
323
审稿时长
1 months
期刊介绍: ACS Chemical Neuroscience publishes high-quality research articles and reviews that showcase chemical, quantitative biological, biophysical and bioengineering approaches to the understanding of the nervous system and to the development of new treatments for neurological disorders. Research in the journal focuses on aspects of chemical neurobiology and bio-neurochemistry such as the following: Neurotransmitters and receptors Neuropharmaceuticals and therapeutics Neural development—Plasticity, and degeneration Chemical, physical, and computational methods in neuroscience Neuronal diseases—basis, detection, and treatment Mechanism of aging, learning, memory and behavior Pain and sensory processing Neurotoxins Neuroscience-inspired bioengineering Development of methods in chemical neurobiology Neuroimaging agents and technologies Animal models for central nervous system diseases Behavioral research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信